Venture studioSmartHealth Catalyzer, Inc. is a biomedical venture studio based in the Midwest, focused on building startups around innovations in therapeutics, diagnostics, and medical devices from local universities and research hospitals.

BioHebe LLC is a New York City-based organization focused on preclinical business development and company formation for therapies targeting degenerative and chronic diseases. It collaborates with academic and healthcare institutions to advance innovative therapies.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
BioHebe LLC is an organization founded in 2017 and based in New York City, NY. It focuses on preclinical business development and company formation for therapies aimed at reversing degenerative and chronic diseases. The organization collaborates with various entities, including university laboratories, academic institutes, hospitals, and early-stage biotech companies.
BioHebe invests in therapies that include gene and RNA vectors, biologics, compounds, stem cells, as well as diagnostics and technologies that support these therapies. The organization is involved in the commercialization of preclinical therapies targeting degenerative diseases such as glaucoma, idiopathic pulmonary fibrosis, and end-stage liver disease. Additionally, BioHebe works on inherited diseases like Usher Syndrome and diagnostics in oncology.
BioHebe offers a unique partnership model for founders, providing access to expertise in preclinical development, business formation, and commercialization strategies. The organization sources and finances cutting-edge therapies, helping to bridge the gap between academic research and viable biotech companies.
BioHebe LLC focuses on pre-seed and seed stage investments in the biotech sector, specifically targeting therapies that address degenerative and chronic diseases.
Founders can reach out via email at info@biohebe.com to discuss potential investment opportunities and pitch their ideas.
BioHebe emphasizes collaboration with academic institutions and hospitals, which enhances their ability to support innovative biotech solutions.
The firm primarily invests in the United States, concentrating on biotech companies that are developing preclinical therapies.
BioHebe actively engages with portfolio companies, providing support in business development and commercialization efforts.
BioHebe invests in a range of therapies, including gene and RNA vectors, biologics, compounds, stem cells, and diagnostics.
Superscout Pro
Is this page right?Reviewed · How the research works